Can machine learning improve patient selection for cardiac resynchronization therapy?

Rationale Multiple clinical trials support the effectiveness of cardiac resynchronization therapy (CRT); however, optimal patient selection remains challenging due to substantial treatment heterogeneity among patients who meet the clinical practice guidelines. Objective To apply machine learning to...

Full description

Bibliographic Details
Main Authors: Santus, Enrico (Author), Forsyth, Alexander W. (Author), Haimson, Josh (Author), Barzilay, Regina (Author)
Other Authors: Massachusetts Institute of Technology. Department of Electrical Engineering and Computer Science (Contributor)
Format: Article
Language:English
Published: Public Library of Science (PLoS), 2020-04-01T11:48:27Z.
Subjects:
Online Access:Get fulltext
LEADER 02995 am a22002533u 4500
001 124468
042 |a dc 
100 1 0 |a Santus, Enrico  |e author 
100 1 0 |a Massachusetts Institute of Technology. Department of Electrical Engineering and Computer Science  |e contributor 
700 1 0 |a Forsyth, Alexander W.  |e author 
700 1 0 |a Haimson, Josh  |e author 
700 1 0 |a Barzilay, Regina  |e author 
245 0 0 |a Can machine learning improve patient selection for cardiac resynchronization therapy? 
260 |b Public Library of Science (PLoS),   |c 2020-04-01T11:48:27Z. 
856 |z Get fulltext  |u https://hdl.handle.net/1721.1/124468 
520 |a Rationale Multiple clinical trials support the effectiveness of cardiac resynchronization therapy (CRT); however, optimal patient selection remains challenging due to substantial treatment heterogeneity among patients who meet the clinical practice guidelines. Objective To apply machine learning to create an algorithm that predicts CRT outcome using electronic health record (EHR) data avaible before the procedure. Methods and results We applied machine learning and natural language processing to the EHR of 990 patients who received CRT at two academic hospitals between 2004-2015. The primary outcome was reduced CRT benefit, defined as <0% improvement in left ventricular ejection fraction (LVEF) 6-18 months post-procedure or death by 18 months. Data regarding demographics, laboratory values, medications, clinical characteristics, and past health services utilization were extracted from the EHR available before the CRT procedure. Bigrams (i.e., two-word sequences) were also extracted from the clinical notes using natural language processing. Patients accrued on average 75 clinical notes (SD, 29) before the procedure including data not captured anywhere else in the EHR. A machine learning model was built using 80% of the patient sample (training and validation dataset), and tested on a held-out 20% patient sample (test dataset). Among 990 patients receiving CRT the mean age was 71.6 (SD, 11.8), 78.1% were male, 87.2% non-Hispanic white, and the mean baseline LVEF was 24.8% (SD, 7.69). Out of 990 patients, 403 (40.7%) were identified as having a reduced benefit from the CRT device (<0% LVEF improvement in 25.2%, death by 18 months in 15.6%). The final model identified 26% of these patients at a positive predictive value of 79% (model performance: Fβ (β = 0.1): 77%; recall 0.26; precision 0.79; accuracy 0.65). Conclusions A machine learning model that leveraged readily available EHR data and clinical notes identified a subset of CRT patients who may not benefit from CRT before the procedure. 
520 |a National Institute of Nursing Research (U.S.) (Grant U24NR014637) 
546 |a en 
690 |a General Biochemistry, Genetics and Molecular Biology 
690 |a General Agricultural and Biological Sciences 
690 |a General Medicine 
655 7 |a Article 
773 |t 10.1371/journal.pone.0222397 
773 |t PLoS one